Trial Profile
Nasal Allergen Challenge Trial of Cat Synthetic Peptide Immunoregulatory Epitopes (Cat-SPIRE)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2015
Price :
$35
*
At a glance
- Drugs Cat SPIRE (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 05 Aug 2015 New trial record